Abbott
![Amulet, Watchman tie in heart occluder study | Pharmtales](https://pharmtales.com/wp-content/uploads/2023/10/Abbotts-Amulet-Bostons-Watchman-equal-in-heart-occluder-trial.jpg)
Abbottâs Amulet, Bostonâs Watchman equal in heart occluder trial
Anika Sharma
The study, presented as a late-breaking feature at the Transcatheter Cardiovascular Therapeutics conference in San Francisco, assessed the safety and ...
![freestyle libre cgm and glp-1 therapy, abbott analysis on cgm and glp-1 ra, cgm and glp-1 improve diabetes outcomes, abbott freestyle libre cgm and glp-1 study, cgm and glp-1 increase medication adherence, abbott diabetes study on cgm and glp-1, freestyle libre cgm and glp-1 benefits,](https://pharmtales.com/wp-content/uploads/2023/09/Abbott-study-shows-FreeStyle-Libre-CGM-and-GLP-1-therapy-improve-diabetes-outcomes.jpg)
Abbott study shows FreeStyle Libre CGM and GLP-1 therapy improve diabetes outcomes
Anika Sharma
In the realm of diabetes management, a symbiotic relationship appears to be flourishing between Continuous Glucose Monitoring (CGM) technology and ...
![Abbott, Bigfoot Biomedical, mergers and acquisitions, Diabetes](https://pharmtales.com/wp-content/uploads/2023/09/Abbott-partners-with-Bigfoot-Biomedical-to-integrate-diabetes-devices.jpg)
Abbott Partners With Bigfoot Biomedical To Integrate Diabetes Devices
Anika Sharma
Abbott has made a significant move by acquiring Bigfoot Biomedical, a diabetes management technology maker. While the financial terms of ...